Pharmaceuticals: Major
Major Mexican companies producing pharmaceuticals
Global pharmaceutical corporations develop and distribute prescription medications at a massive scale. Patent expirations, pipeline approvals, and healthcare legislation serve as major catalysts for trading activity and industry liquidity. Market data indicates that Genomma Lab Internacional SAB de CV Class B is currently the highest-volume asset, while Swedish Orphan Biovitrum AB tops the 24-hour return list. The table below tracks the vital technical and fundamental metrics for these equities.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 24.86 T MXN | 25,456.64 MXN | −3.26% | 64 | 0.20 | 46.24 | 550.53 MXN | +48.52% | 0.47% | Health technology | Strong buy |
| LLYEli Lilly and Company | 24.86 T MXN | 25,447.94 MXN | −2.01% | 176 | 0.21 | 46.22 | 550.53 MXN | +48.52% | 0.47% | Health technology | Strong buy |
 JNJJohnson & Johnson | 12.4 T MXN | 5,115.00 MXN | −0.49% | 60 | 0.56 | 42.90 | 119.23 MXN | −37.23% | 1.91% | Health technology | Buy |
| JNJJohnson & Johnson | 12.4 T MXN | 5,115.00 MXN | +0.10% | 471 | 0.70 | 42.90 | 119.23 MXN | −37.23% | 1.91% | Health technology | Buy |
 ABBVAbbVie, Inc. | 9.71 T MXN | 5,386.00 MXN | −3.99% | 94 | 0.46 | 51.25 | 105.09 MXN | +332.56% | 2.35% | Health technology | Buy |
| ABBVAbbVie, Inc. | 9.71 T MXN | 5,420.00 MXN | −1.07% | 155 | 0.80 | 51.57 | 105.09 MXN | +332.56% | 2.35% | Health technology | Buy |
 ROP1/NRoche Holding Ltd | 7.2 T MXN | 8,860.10 MXN | 0.00% | 165 | 1.48 | 26.70 | 331.88 MXN | +19.51% | 2.48% | Health technology | Buy |
 MRKMerck & Co., Inc. | 6.91 T MXN | 2,747.80 MXN | −3.33% | 54 | 0.17 | 155.15 | 17.71 MXN | −87.22% | 2.26% | Health technology | Buy |
| MRKMerck & Co., Inc. | 6.91 T MXN | 2,737.00 MXN | −2.46% | 196 | 0.26 | 154.54 | 17.71 MXN | −87.22% | 2.26% | Health technology | Buy |
 NVS/NNovartis AG Sponsored ADRDR | 5.6 T MXN | 3,016.73 MXN | +0.24% | 1.28 K | 37.35 | 31.85 | 94.70 MXN | −29.57% | 1.87% | Health technology | Buy |
| NOVN/NNovartis AG | 5.6 T MXN | 2,602.21 MXN | 0.00% | 445 | 1.17 | 28.99 | 89.78 MXN | −37.05% | 2.76% | Health technology | Neutral |
 AZN1/NAstraZeneca PLC | 5.46 T MXN | 3,518.42 MXN | 0.00% | 111 | 0.09 | 27.85 | 126.33 MXN | +11.14% | 1.70% | Health technology | Buy |
| AZN1/NAstraZeneca PLC | 5.46 T MXN | 3,505.21 MXN | +7.85% | 1.27 K | 0.28 | 27.75 | 126.33 MXN | +11.14% | 1.70% | Health technology | Buy |
 NOVOB/NNovo Nordisk A/S Class B | 3.53 T MXN | 709.00 MXN | −5.47% | 139 | 0.17 | 10.18 | 69.67 MXN | +4.07% | 4.10% | Health technology | Neutral |
| NOVOB/NNovo Nordisk A/S Class B | 3.53 T MXN | 712.00 MXN | −1.11% | 46 | 0.99 | 10.22 | 69.67 MXN | +4.07% | 4.10% | Health technology | Neutral |
| NVO/NNovo Nordisk A/S Sponsored ADR Class B DR | 3.53 T MXN | 749.80 MXN | −0.69% | 347 | 0.12 | 10.44 | 71.80 MXN | +14.12% | 2.92% | Health technology | Neutral |
 PFEPfizer Inc. | 3.27 T MXN | 545.00 MXN | −2.96% | 3.51 K | 0.62 | 43.10 | 12.65 MXN | −59.79% | 5.59% | Health technology | Neutral |
| PFEPfizer Inc. | 3.27 T MXN | 549.56 MXN | −2.15% | 1.41 K | 1.34 | 43.46 | 12.65 MXN | −59.79% | 5.59% | Health technology | Neutral |
 VRTXVertex Pharmaceuticals Incorporated | 2.59 T MXN | 9,620.01 MXN | +1.78% | 12 | 0.02 | 34.21 | 281.17 MXN | +8.10% | 0.00% | Health technology | Buy |
| VRTXVertex Pharmaceuticals Incorporated | 2.59 T MXN | 10,060.63 MXN | 0.00% | 5 | 0.02 | 35.78 | 281.17 MXN | +8.10% | 0.00% | Health technology | Buy |
 BMYBristol-Myers Squibb Company | 2.45 T MXN | 1,190.00 MXN | 0.00% | 1 | 0.01 | 14.58 | 81.63 MXN | +50.35% | 3.93% | Health technology | Buy |
| BMYBristol-Myers Squibb Company | 2.45 T MXN | 1,190.00 MXN | −0.01% | 78 | 0.21 | 14.58 | 81.63 MXN | +50.35% | 3.93% | Health technology | Buy |
 SNY/NSanofi SA Sponsored ADRDR | 2.11 T MXN | 855.00 MXN | +0.88% | 57 | 0.04 | 25.16 | 33.99 MXN | −35.53% | 3.72% | Health technology | Buy |
| SAN1/NSanofi SA | 2.11 T MXN | 1,532.71 MXN | 0.00% | 2.76 K | 1.03 | 23.03 | 66.55 MXN | −41.74% | 4.90% | Health technology | Buy |
 GSK/NGSK plc Sponsored ADRDR | 1.9 T MXN | 960.00 MXN | +0.95% | 9 | 0.33 | 18.50 | 51.88 MXN | −19.27% | 3.49% | Health technology | Buy |
 REGNRegeneron Pharmaceuticals, Inc. | 1.79 T MXN | 18,330.00 MXN | 0.00% | 1.88 K | 8.12 | 22.37 | 819.27 MXN | +6.99% | 0.40% | Health technology | Buy |
 2359/NWuXi AppTec Co., Ltd. Class H | 1.26 T MXN | 483.34 MXN | +36.11% | 1.11 K | — | 20.81 | 23.23 MXN | +80.11% | 1.21% | Health technology | Strong buy |
 TAK/NTakeda Pharmaceutical Co. Ltd. Sponsored ADRDR | 1.24 T MXN | 345.00 MXN | +7.81% | 139 | 0.01 | 310.16 | 1.11 MXN | −22.90% | 2.76% | Health technology | Buy |
 UCB/NUCB S.A. | 1.12 T MXN | 1,692.27 MXN | 0.00% | 403 | 0.35 | 7.49 | 226.02 MXN | +49.26% | 0.36% | Health technology | Buy |
 BAYN/NBayer AG | 1.11 T MXN | 953.08 MXN | −4.69% | 202 | 4.96 | — | −35.37 MXN | +54.00% | 0.20% | Health technology | Buy |
 GALD/NGalderma Group AG | 1.03 T MXN | 4,195.64 MXN | +6.05% | 548 | 0.48 | 66.72 | 62.88 MXN | +92.99% | 0.18% | Health technology | Buy |
 HLN/NHaleon PLC | 744.71 B MXN | 99.17 MXN | 0.00% | 1.61 K | 0.09 | 23.59 | 4.20 MXN | −2.34% | 2.16% | Health technology | Buy |
| HLN1/NHaleon PLC Sponsored ADR DR | 744.71 B MXN | 170.00 MXN | −0.58% | 32 | 0.01 | 19.97 | 8.51 MXN | +4.87% | 2.03% | Health technology | Buy |
 RPRX/NRoyalty Pharma Plc Class A | 725.7 B MXN | 1,213.52 MXN | +15.66% | 4.1 K | 0.56 | 43.66 | 27.80 MXN | −13.29% | 1.37% | Health technology | Buy |
 BIIBBiogen Inc. | 700.98 B MXN | 4,689.60 MXN | 0.00% | 3 | 0.00 | 111.00 | 42.25 MXN | −78.98% | 0.00% | Health technology | Buy |
| BIIBBiogen Inc. | 700.98 B MXN | 4,722.55 MXN | +9.97% | 3.2 K | 55.17 | 111.78 | 42.25 MXN | −78.98% | 0.00% | Health technology | Buy |
 ZTSZoetis, Inc. Class A | 686.91 B MXN | 1,550.00 MXN | 0.00% | 1 | 0.02 | 14.57 | 106.40 MXN | −2.40% | 2.38% | Health technology | Neutral |
| ZTSZoetis, Inc. Class A | 686.91 B MXN | 1,623.29 MXN | +5.08% | 324 | 5.65 | 15.26 | 106.40 MXN | −2.40% | 2.38% | Health technology | Neutral |
 INCYIncyte Corporation | 466.66 B MXN | 1,988.32 MXN | 0.00% | 1 | 0.00 | 58.50 | 33.99 MXN | −68.90% | 0.00% | Health technology | Buy |
 INSMInsmed Incorporated | 449.72 B MXN | 1,757.82 MXN | 0.00% | 1 | 0.01 | — | −50.93 MXN | +55.05% | 0.00% | Health technology | Strong buy |
 VTRSViatris, Inc. | 411.4 B MXN | 349.02 MXN | +6.28% | 20 | 0.10 | — | −6.25 MXN | +88.54% | 2.50% | Health technology | Buy |
| VTRSViatris, Inc. | 411.4 B MXN | 364.00 MXN | +20.53% | 158 | 0.02 | — | −6.25 MXN | +88.54% | 2.50% | Health technology | Buy |
 ALNYAlnylam Pharmaceuticals, Inc | 402.06 B MXN | 5,549.00 MXN | 0.00% | 2 | 0.03 | 15.50 | 358.09 MXN | +8,025.55% | 0.00% | Health technology | Buy |
| ALNYAlnylam Pharmaceuticals, Inc | 402.06 B MXN | 4,255.00 MXN | −30.96% | 10 | — | 11.88 | 358.09 MXN | +8,025.55% | 0.00% | Health technology | Buy |
 SOBI/NSwedish Orphan Biovitrum AB | 317.5 B MXN | 903.50 MXN | +181.40% | 1.92 K | 0.14 | 26.52 | 34.07 MXN | — | 0.00% | Health technology | Buy |
 REC/NRecordati S.p.A. | 229.28 B MXN | 1,109.40 MXN | +8.79% | 2.88 K | 2.36 | 23.32 | 47.58 MXN | +10.59% | 2.52% | Health technology | Neutral |
 IBRXImmunityBio Inc | 176.38 B MXN | 164.00 MXN | — | 40 | — | — | −16.96 MXN | −83.41% | 0.00% | Health technology | Strong buy |
 ACADACADIA Pharmaceuticals Inc. | 68.94 B MXN | 389.00 MXN | +2.42% | 41 | 0.31 | 10.01 | 38.87 MXN | +55.69% | 0.00% | Health technology | Buy |
 OGNOrganon & Co. | 67.69 B MXN | 255.00 MXN | 0.00% | 2 | 0.04 | 18.34 | 13.90 MXN | −60.58% | 0.58% | Health technology | Neutral |
 ROVI/NLaboratorios Farmaceuticos Rovi, S.A. | 67.45 B MXN | 1,449.78 MXN | +8.82% | 645 | 1.21 | 20.03 | 72.38 MXN | +26.06% | 1.22% | Health technology | Buy |
 PRGO/NPerrigo Co. Plc | 40.94 B MXN | 280.00 MXN | 0.00% | 1 | 0.00 | — | −230.81 MXN | −3,242.42% | 7.33% | Health technology | Neutral |
 SRPTSarepta Therapeutics, Inc. | 37.38 B MXN | 350.00 MXN | 0.00% | 2 | 0.01 | — | −50.72 MXN | −256.41% | 0.00% | Health technology | Neutral |
 HRMYHarmony Biosciences Holdings, Inc. | 37.35 B MXN | 714.50 MXN | +1.93% | 500 | — | 13.05 | 54.75 MXN | −5.94% | 0.00% | Health technology | Buy |
 RAREUltragenyx Pharmaceutical, Inc. | 31.53 B MXN | 256.00 MXN | −7.56% | 250 | — | — | −93.85 MXN | +13.80% | 0.00% | Health technology | Buy |
 LAB/BGenomma Lab Internacional SAB de CV Class B | 15.49 B MXN | 16.00 MXN | +5.82% | 273.52 K | 0.95 | 9.16 | 1.75 MXN | −3.07% | 5.16% | Health technology | Buy |
| LAB/BGenomma Lab Internacional SAB de CV Class B | 15.49 B MXN | 15.94 MXN | +5.56% | 3.72 M | 0.79 | 9.12 | 1.75 MXN | −3.07% | 5.16% | Health technology | Buy |
 OCGNOcugen Inc | 5.53 B MXN | 16.90 MXN | +5.62% | 4.29 K | 2.31 | — | −3.60 MXN | +9.26% | 0.00% | Health technology | Strong buy |
| OCGNOcugen Inc | 5.53 B MXN | 16.42 MXN | −0.48% | 3.82 K | 13.03 | — | −3.60 MXN | +9.26% | 0.00% | Health technology | Strong buy |
 INOInovio Pharmaceuticals, Inc. | 3.12 B MXN | 27.40 MXN | −8.79% | 2.04 K | 6.88 | — | −20.58 MXN | +57.91% | 0.00% | Health technology | Strong buy |
| INOInovio Pharmaceuticals, Inc. | 3.12 B MXN | 22.00 MXN | −19.71% | 9.69 K | 7.09 | — | −20.58 MXN | +57.91% | 0.00% | Health technology | Strong buy |
 ATOSAtossa Therapeutics, Inc. | 394.26 M MXN | 36.50 MXN | −13.10% | 114 | 0.78 | — | −76.05 MXN | −20.21% | 0.00% | Health technology | Strong buy |
| ATOSAtossa Therapeutics, Inc. | 394.26 M MXN | 38.01 MXN | −15.53% | 5 | 0.04 | — | −76.05 MXN | −20.21% | 0.00% | Health technology | Strong buy |